Company Results1 Min Read InvestyWise NewsonNovember 7, 2025 Schneider Electric Board Approves Q2 Results, Director Appointments Schneider Electric Infrastructure Limited’s board has approved the unaudited financial results for Q2 2025, ending September 30, 2025.…
Company Update1 Min Read InvestyWise NewsonNovember 7, 2025 Krishna Institute of Medical Sciences Merger of KIMS Hospitals and Chalasani Hospitals Approved Krishna Institute of Medical Sciences (KIMS) has announced the approval of the merger between its wholly-owned subsidiaries, KIMS Hospitals…
Company Update2 Min Read InvestyWise NewsonNovember 7, 2025 Affle 3i Q2 FY2026 Earnings Call Transcript Highlights Growth & AI Integration Affle 3i reported robust Q2 FY2026 results with a 19.1% year-over-year revenue growth, reaching INR 6,467 million. Key highlights include a…
Insider Trading / SAST1 Min Read InvestyWise NewsonNovember 7, 2025 Havells India LIC Increases Stake to 7.043% Life Insurance Corporation of India (LIC) has increased its stake in Havells India Ltd to 7.043%. The acquisition involved the purchase of…
Board Meeting1 Min Read InvestyWise NewsonNovember 7, 2025 Schneider Electric Board Approves Q2 Results and Postal Ballot for Director Appointments Schneider Electric Infrastructure Limited’s board approved the unaudited financial results for Q2 2025, ending September 30, 2025.…
Company Update1 Min Read InvestyWise NewsonNovember 7, 2025 Astral Limited Clarification on Recent Volume Increase in Shares Astral Limited has addressed inquiries regarding the significant increase in its share volume across exchanges. The company stated that it…
Company Update1 Min Read InvestyWise NewsonNovember 7, 2025 Aegis Vopak Acquisition & Strong Financials Highlight Expansion Aegis Vopak Terminals Limited (AVTL) reports strong Q2 FY26 results driven by increased LPG throughput and strategic expansions. Key…
Company Update1 Min Read InvestyWise NewsonNovember 7, 2025 Piramal Pharma Transcript of Conference Call on Unaudited Financial Results Piramal Pharma has announced the availability of the transcript from its conference call held on November 6th, 2025, regarding the unaudited…
Company Update2 Min Read InvestyWise NewsonNovember 7, 2025 NAVA Limited Q2 FY26 Financial Highlights and Investor Presentation NAVA Limited has released its investor presentation for the quarter ended September 30, 2025. The presentation highlights financial…
Company Update2 Min Read InvestyWise NewsonNovember 7, 2025 Alembic Pharmaceuticals Receives USFDA Final Approval for Sumatriptan Injection Alembic Pharmaceuticals has received USFDA final approval for Sumatriptan Injection USP, specifically the 4 mg/0.5 mL and 6 mg/0.5 mL…